A Trial of SHR-4849 Combined With Other Antitumor Drugs in Patients With Malignant Solid Tumors
NCT07028281
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
120
Enrollment
INDUSTRY
Sponsor class
Conditions
Malignant Solid Tumors
Interventions
DRUG:
SHR-4849、SHR-1316、SHR-8068、BP102、carboplatin、cisplatin
Sponsor
Suzhou Suncadia Biopharmaceuticals Co., Ltd.